Clinical trials: Eligible for Vaccination Against Influenza

Egg Allergy, Eligible for Vaccination Against Influenza

FluMist in Egg Allergic Patients

• Completed
• Age: 6 months and older
• Phase 1/2
• Vaccines
• Injection or infusion

With the growing public health concerns of seasonal influenza and H1N1 in the United States, the primary means by which this can be addressed is with prevention, namely, vaccination against the influenza virus.

Trial name

FluEMIST (NCT01248208)

Testing

FluMist intranasal influenza vaccine, Intramuscular influenza injection ("flu shot")

Where

United States

Volunteers

17 people

Sponsor

Walter Reed Army Medical Center